Navigation Links
GSK Charitable Support Valued at $564 Million in 2007

LONDON, March 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today reported its 2007 global giving to charitable initiatives totaled $564 million, equivalent to almost 4% of pre-tax profits for the company (with the FTSE 100 average around 1%). Donations of albendazole treatments for the company's flagship program to eliminate Lymphatic Filariasis (commonly known as elephantiasis) were valued at $29 million, bringing the total number of treatments given since GSK made its commitment 10 years ago to almost 750 million.

Commenting on the figures JP Garnier, CEO of GlaxoSmithKline said: "I want GSK to be part of global healthcare solutions, not only through our medicines and vaccines, but also through our public health programs and work with communities. This is embedded in our business, not just an 'add on'; whether it is eliminating LF, supporting HIV communities, fighting malaria, or preventing diabetes. Our partnerships offer more than a helping hand; they are transforming the lives and prospects of people all over the world."

GSK supports health and education programs in more than 100 countries through donations of medicines and through long-term partnerships that provide financial and practical support. The $564 million investment includes product donations valued at $448 million, cash giving of $82 million and other in-kind donations, such as equipment, valued at $6 million. The costs to administer and deliver these programs were $28 million.

The $448 million of product donations included:

-- A continuation of the Lymphatic Filariasis elimination program which

since 1998 has seen the donation of almost 750 million albendazole

treatments by GSK. This program, now in the tenth year of GSK's

involvement working with the World Health Organization and other

partners aims to eliminate LF by 2020.

-- $31 million of humanitarian product donations for the most impoverished

communities and international relief efforts, including the cyclone in

Bangladesh and floods in Mexico. GSK provides significant quantities of

essential quality medicines through a proven crisis response process.

-- $388 million provided via Patient Assistance Programs (PAP) for low

income patients in the USA. GSK provides $1 million in medicines per

day to patients who cannot afford to pay for their prescriptions. These

include products that are able to be used in an outpatient setting

across all therapeutic areas, such as: respiratory, psychiatric,

neurology, metabolic, CV.

Cash donations of $82 million delivered through partnerships with hundreds of charitable organizations.

-- Over $41 million was directed to global and local health programs.

With GSK funding the Malaria Consortium is delivering 'Mobilizing for

Malaria', a program to increase awareness and mobilize resources for

this killer disease. In its 15th year, GSK's Positive Action for HIV

and AIDS delivered effective education, prevention and health care

services in 19 countries. GSK's PHASE (Personal Hygiene And Sanitation

Education) program continues to grow now reaching half a million

school children in 12 countries, helping to prevent diarrhoeal diseases

through better hand-washing.

-- Donations of almost $23 million supported education programs,

including science education and literacy. Through Crest Star

Investigators school children will have access to engaging science

activities at their UK after-school clubs. The target is to reach 5,000

schools and 55,000 children by 2010. GSK's 'Science in the Summer'

enables 6000 children in Philadelphia to participate in hands-on

experiments in libraries. GSK continues to support the Institute for a

Competitive Workforce, a business coalition staffed by the Business

Civic Leadership Center of the US Chamber of Commerce. This is aimed at

improving education and creating a skilled workforce for the future.

In addition to the company donations GlaxoSmithKline employees contributed more than $7 million to charities in the UK and US through employee-organized giving programs. Many also gave their time and skills to their local communities. Further details of GSK's giving and activities relating to other corporate responsibility areas are published today in GSK Corporate Responsibility report on

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Virginia G. Piper Charitable Trust and Flinn Foundation launch
2. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
3. Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
4. Online Charitable Holiday Giving: Making a Difference with the Gifts You Give
5. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
6. China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues
7. MDS Designates Cancer its Major Charitable Cause on World Cancer Day
8. HIV therapy in pregnancy-data support WHO recommendations
9. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
10. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
11. Family-based treatment more effective than supportive psychotherapy in treating bulimia
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a ... to celebrate their sobriety and show through pictures what a positive difference it ... this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon ... programs, launches new Wimbledon Athletics Facebook page to educate the public, ... unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die from ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Smiles by ... TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the ... the great success Botox® delivers to those suffering with discomfort, soreness, and pain as ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of music, friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for ... , For 65 years, Brillianteen has been a treasured tradition for ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against ... nation’s roadways has dropped below 10,000 for the first time since 2011. In 2014, ... , According to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
Breaking Medicine Technology: